MGC Pharma receives TGA approval to market epilepsy drug in Australia

Australia's MGC Pharmaceuticals is pleased to announce the receipt of formal authorisation for the availability of its p...

October 11, 2018 | Thursday | News
One-third unplanned pregnancies aborted in Australia, says a survey

One in three unwanted pregnancies end in abortion, if recent research undertaken in Australia is any indication. The re...

October 8, 2018 | Monday | News
RMIT, Atmo sign licence agreement for gut sensors

RMIT University in Australia has signed a commercial licence agreement with start-up Atmo Biosciences for ingestible sen...

October 3, 2018 | Wednesday | News
Invion spin-off selects leading CRO for nadolol development

Singapore - Chronic Airway Therapeutics (CAT), a proposed spin-off from Invion Limited, has selected leading Chinese con...

September 27, 2018 | Thursday | News
Virtus appoints new non-executive director

Singapore – Virtus Health announces the appointment of Shane Solomon to its Board as a Non-Executive Director. Sol...

September 27, 2018 | Thursday | News
Sun Pharma announces Australian TGA approval of ILUMYA

India's Sun Pharmaceutical recently announced that Sun Pharma has received the Australian Therapeutic Goods Administrati...

September 25, 2018 | Tuesday | News
Minomic announces demerger of Glytherix

Minomic International Ltd has announced that it received strong shareholder approval to approve the demerger of its...

September 25, 2018 | Tuesday | News
Immutep collaborates with Merck, Pfizer for Efti

Immutep Limited has announced that it has entered into a clinical trial collaboration and supply agreement with Merck KG...

September 25, 2018 | Tuesday | News
Daily intake of Aspirin has little effect on cardiovascular disease, says a study

Three groundbreaking papers published in New England Journal of Medicine, led by a team of Monash University researchers...

September 17, 2018 | Monday | News
Invion to spinout respiratory assets, advance clinical development in China

Australia-based Invion recently announced plans to  spin off its two assets aimed at treating chronic airway diseas...

September 12, 2018 | Wednesday | News
Cancer Australia releases new diagnostic data

For the first time, national data on childhood cancer stage at diagnosis has been released, showing that a high proporti...

September 11, 2018 | Tuesday | News
Photosoft granted patent protection in Australia

Singapore - ASX-listed life- sciences company, Invion Limited announces the grant in Australia of the patent for chlorin...

September 10, 2018 | Monday | News
Centre marks new era in Israel-Australia research

Singapore - A new Israel-Australia research centre involving a major collaboration with Monash University will...

September 6, 2018 | Thursday | News
Vertex announces reimbursement agreement in Australia for ORKAMBI

Vertex Pharmaceuticals announced the finalization of an agreement with the Australian Government that allows for reimbur...

September 5, 2018 | Wednesday | News
Cadrock gets $5M seed funding for heart therapy

Cadrock Pty Ltd, which owns an investigational prevention and treatment therapy for coronary artery disease (CAD), has s...

September 4, 2018 | Tuesday | News
Australian scientists detect cancer with gold plated nanoparticles

Researchers from the University of New South Wales (UNSW Sydney) in Australia have used gold-plated nanoparticles to det...

August 30, 2018 | Thursday | News
BGI, Xing Tech to advance diagnostic technologies

Beijing Genomics Institute (BGI) has signed a Memorandum of Understanding (MoU) with Australian firm Xing Technology aim...

August 27, 2018 | Monday | News
Merck receives Australian CRISPR Nickase Patent

Merck, the vibrant science and technology company has announced that the Australian Patent Office has allowed the compan...

August 16, 2018 | Thursday | News

Podcast

Survey Box

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls